Danaher Corporation (DHR) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Danaher Corporation stock (DHR) is currently trading at $187.15. Danaher Corporation PE ratio is 37.72. Danaher Corporation PS ratio (Price-to-Sales) is 5.47. Analyst consensus price target for DHR is $264.91. WallStSmart rates DHR as Hold.
Danaher Corporation (DHR) stock price prediction for 2030: Base case $80.70. Bull case $100.88. Bear case $60.53. See full DHR 2030 price forecast and methodology on WallStSmart.
- DHR PE ratio analysis and historical PE chart
- DHR PS ratio (Price-to-Sales) history and trend
- DHR intrinsic value — DCF, Graham Number, EPV models
- DHR stock price prediction 2025 2026 2027 2028 2029 2030
- DHR fair value vs current price
- DHR insider transactions and insider buying
- Is DHR undervalued or overvalued?
- Danaher Corporation financial analysis — revenue, earnings, cash flow
- DHR Piotroski F-Score and Altman Z-Score
- DHR analyst price target and Smart Rating
Danaher Corporation
📊 No data available
Try selecting a different time range
DHR Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Danaher Corporation (DHR)
DHR trades 39% above its Graham fair value of $135.07, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Danaher Corporation (DHR) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in market cap, peg ratio, operating margin. Concerns around return on equity and revenue growth. Fundamentals are solid but monitor weak areas for improvement.
Danaher Corporation (DHR) Key Strengths (4)
84.58% of shares held by major funds and institutions
Large-cap company with substantial market presence
Good growth relative to its price
Strong operational efficiency: $22 kept per $100 revenue
Supporting Valuation Data
Danaher Corporation (DHR) Areas to Watch (6)
Revenue growing slowly at 4.60% annually
Low profitability relative to shareholder equity
Premium valuation at 5.5x annual revenue
Fairly priced relative to book value
Solid earnings growth at 12.50%
Decent profitability, keeps $15 per $100 revenue
Supporting Valuation Data
Danaher Corporation (DHR) Detailed Analysis Report
Overall Assessment
This company scores 60/100 in our Smart Analysis, earning a C grade. Out of 10 metrics analyzed, 4 register as strengths (avg 8.8/10) while 6 fall into concern territory (avg 4.5/10). All four categories (Growth, Profitability, Valuation, and Quality) show healthy scores, indicating broadly sound fundamentals.
The Bull Case
The strongest argument centers on Institutional Own., Market Cap, PEG Ratio. Valuation metrics including PEG Ratio (1.23) suggest the stock is attractively priced. Profitability is solid with Operating Margin at 22.20%.
The Bear Case
The primary concerns are Revenue Growth, Return on Equity, Price/Sales. Some valuation metrics including Price/Sales (5.47), Price/Book (2.55) suggest expensive pricing. Growth concerns include Revenue Growth at 4.60%, EPS Growth at 12.50%, which may limit upside. Profitability pressure is visible in Return on Equity at 7.05%, Profit Margin at 14.70%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Revenue Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 7.05% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 4.60% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (Institutional Own., Market Cap) and negatives (Revenue Growth, Return on Equity). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
DHR Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
DHR's Price-to-Sales ratio of 5.47x trades 60% above its historical average of 3.42x (97th percentile), historically expensive. The current valuation is 6% below its historical high of 5.81x set in Mar 2026, and 179% above its historical low of 1.96x in Sep 2011.
WallStSmart Analysis Synopsis
Data-driven financial summary for Danaher Corporation (DHR) · HEALTHCARE › DIAGNOSTICS & RESEARCH
The Big Picture
Danaher Corporation is a strong growth company balancing expansion with improving profitability. Revenue reached 24.6B with 460% growth year-over-year. Profit margins of 14.7% are healthy, with room for further expansion as the business scales.
Key Findings
Revenue growing at 460% YoY, reaching 24.6B. This pace significantly outperforms most DIAGNOSTICS & RESEARCH peers.
ROE of 705.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
What to Watch Next
Margin expansion: can Danaher Corporation push profit margins above 15% as the business scales?
Growth sustainability: can Danaher Corporation maintain 460%+ revenue growth, or will competition slow it down?
Sector dynamics: monitor DIAGNOSTICS & RESEARCH industry trends, competitive moves, and regulatory changes that could impact Danaher Corporation.
Bottom Line
Danaher Corporation offers an attractive blend of growth (460% revenue expansion) and improving fundamentals. The company is transitioning from pure growth to profitable growth, a critical inflection point. Watch for sustained margin expansion as the key signal.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Danaher Corporation(DHR)
NYSE
HEALTHCARE
DIAGNOSTICS & RESEARCH
USA
Danaher Corporation is an American globally diversified conglomerate with its headquarters in Washington, D.C.. The company designs, manufactures, and markets professional, medical, industrial, and commercial products and services. The company's 3 platforms are Life Sciences, Diagnostics, and Environmental & Applied Solutions.